Skip to main content
SpringerLink
Log in

Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hicheri Y, Cook G, Cordonnier C. Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect. 2012;18:1–15.

    Article  CAS  PubMed  Google Scholar 

  2. Marks DI, Pagliuca A, Kibbler CC, et al. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol. 2011;155:318–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Marr KA, Crippa F, Leisenring W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood. 2004;103:1527–33.

    Article  CAS  PubMed  Google Scholar 

  4. Hoenigl M, Salzer HJ, Raggam RB, et al. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol. 2012;50:266–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hoenigl M, Duettmann W, Raggam RB, et al. Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother. 2013;57:3262–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

M. Hoenigl had received a research grant for investigator-initiated study from Pfizer and Merck. The other authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria

    M. Hoenigl, K. Seeber & R. Krause

  2. Division of Pulmonology, Medical University of Graz, Graz, Austria

    M. Hoenigl

Authors
  1. M. Hoenigl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Seeber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Hoenigl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoenigl, M., Seeber, K. & Krause, R. Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?. Infection 42, 233–234 (2014). https://doi.org/10.1007/s15010-013-0562-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0562-4

Keywords

Search

Navigation